Secnidazole: Several epidemiologic studies do not show an increased risk of congenital anomalies associated with exposure in pregnancy. The data from two hundred pregnant female treated for entamoeba histolytica, did not show any adverse fetal effects. Discuss with your doctor.
Answered 8/24/2017
574 views
A doctor has provided 1 answer
A doctor has provided 1 answer
2 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question